These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 24135281)

  • 1. The role of Cdk5 in neuroendocrine thyroid cancer.
    Pozo K; Castro-Rivera E; Tan C; Plattner F; Schwach G; Siegl V; Meyer D; Guo A; Gundara J; Mettlach G; Richer E; Guevara JA; Ning L; Gupta A; Hao G; Tsai LH; Sun X; Antich P; Sidhu S; Robinson BG; Chen H; Nwariaku FE; Pfragner R; Richardson JA; Bibb JA
    Cancer Cell; 2013 Oct; 24(4):499-511. PubMed ID: 24135281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of cell cycle regulators in CDK5-dependent medullary thyroid carcinoma tumorigenesis.
    Pozo K; Hillmann A; Augustyn A; Plattner F; Hai T; Singh T; Ramezani S; Sun X; Pfragner R; Minna JD; Cote GJ; Chen H; Bibb JA; Nwariaku FE
    Oncotarget; 2015 May; 6(14):12080-93. PubMed ID: 25900242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RET Regulates Human Medullary Thyroid Cancer Cell Proliferation through CDK5 and STAT3 Activation.
    Yue CH; Oner M; Chiu CY; Chen MC; Teng CL; Wang HY; Hsieh JT; Lai CH; Lin H
    Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34207842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cdk5 regulates STAT3 activation and cell proliferation in medullary thyroid carcinoma cells.
    Lin H; Chen MC; Chiu CY; Song YM; Lin SY
    J Biol Chem; 2007 Feb; 282(5):2776-84. PubMed ID: 17145757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortalin (GRP75/HSPA9) upregulation promotes survival and proliferation of medullary thyroid carcinoma cells.
    Starenki D; Hong SK; Lloyd RV; Park JI
    Oncogene; 2015 Aug; 34(35):4624-34. PubMed ID: 25435367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced Retinoblastoma Protein Expression Is Associated with Decreased Patient Survival in Medullary Thyroid Cancer.
    Valenciaga A; Grubbs EG; Porter K; Wakely PE; Williams MD; Cote GJ; Vasko VV; Saji M; Ringel MD
    Thyroid; 2017 Dec; 27(12):1523-1533. PubMed ID: 29105562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cofilin is a mediator of RET-promoted medullary thyroid carcinoma cell migration, invasion and proliferation.
    Giardino E; Catalano R; Barbieri AM; Treppiedi D; Mangili F; Spada A; Arosio M; Mantovani G; Peverelli E
    Mol Cell Endocrinol; 2019 Sep; 495():110519. PubMed ID: 31352037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LINC00887 Acts as an Enhancer RNA to Promote Medullary Thyroid Carcinoma Progression by Binding with FOXQ1.
    Liu D; Wang W; Wu Y; Qiu Y; Zhang L
    Curr Cancer Drug Targets; 2024; 24(5):519-533. PubMed ID: 38804344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of the NOTCH1 intracellular domain inhibits cell proliferation and alters the neuroendocrine phenotype of medullary thyroid cancer cells.
    Kunnimalaiyaan M; Vaccaro AM; Ndiaye MA; Chen H
    J Biol Chem; 2006 Dec; 281(52):39819-30. PubMed ID: 17090547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leflunomide suppresses growth in human medullary thyroid cancer cells.
    Alhefdhi A; Burke JF; Redlich A; Kunnimalaiyaan M; Chen H
    J Surg Res; 2013 Nov; 185(1):212-6. PubMed ID: 23816245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of aberrant cyclin-dependent kinase 5/p25 activity in experimental traumatic brain injury.
    Yousuf MA; Tan C; Torres-Altoro MI; Lu FM; Plautz E; Zhang S; Takahashi M; Hernandez A; Kernie SG; Plattner F; Bibb JA
    J Neurochem; 2016 Jul; 138(2):317-27. PubMed ID: 26998748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analytical Performance of a Gene Expression Classifier for Medullary Thyroid Carcinoma.
    Pankratz DG; Hu Z; Kim SY; Monroe RJ; Wong MG; Traweek ST; Kloos RT; Walsh PS; Kennedy GC
    Thyroid; 2016 Nov; 26(11):1573-1580. PubMed ID: 27605259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of CDKN2C Copy Number in Sporadic Medullary Thyroid Carcinoma.
    Grubbs EG; Williams MD; Scheet P; Vattathil S; Perrier ND; Lee JE; Gagel RF; Hai T; Feng L; Cabanillas ME; Cote GJ
    Thyroid; 2016 Nov; 26(11):1553-1562. PubMed ID: 27610696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 suppresses carcinoma progression by inhibiting mTOR pathway activation.
    Akeno N; Miller AL; Ma X; Wikenheiser-Brokamp KA
    Oncogene; 2015 Jan; 34(5):589-99. PubMed ID: 24469052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. YAP confers resistance to vandetanib in medullary thyroid cancer.
    Wang H; Tang J; Su Z
    Biochem Cell Biol; 2020 Jun; 98(3):443-448. PubMed ID: 32449862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of MEN2A-derived RET in maintenance and proliferation of medullary thyroid carcinoma.
    Drosten M; Hilken G; Böckmann M; Rödicker F; Mise N; Cranston AN; Dahmen U; Ponder BA; Pützer BM
    J Natl Cancer Inst; 2004 Aug; 96(16):1231-9. PubMed ID: 15316058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suberoyl bishydroxamic acid activates notch1 signaling and suppresses tumor progression in an animal model of medullary thyroid carcinoma.
    Ning L; Jaskula-Sztul R; Kunnimalaiyaan M; Chen H
    Ann Surg Oncol; 2008 Sep; 15(9):2600-5. PubMed ID: 18563491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. circPVT1 regulates medullary thyroid cancer growth and metastasis by targeting miR-455-5p to activate CXCL12/CXCR4 signaling.
    Zheng X; Rui S; Wang XF; Zou XH; Gong YP; Li ZH
    J Exp Clin Cancer Res; 2021 May; 40(1):157. PubMed ID: 33962657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the active Notch1 decreases MTC tumor growth in vivo.
    Jaskula-Sztul R; Pisarnturakit P; Landowski M; Chen H; Kunnimalaiyaan M
    J Surg Res; 2011 Nov; 171(1):23-7. PubMed ID: 21571316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ATF4 Targets RET for Degradation and Is a Candidate Tumor Suppressor Gene in Medullary Thyroid Cancer.
    Bagheri-Yarmand R; Williams MD; Grubbs EG; Gagel RF
    J Clin Endocrinol Metab; 2017 Mar; 102(3):933-941. PubMed ID: 27935748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.